| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Vorinostat | CTRPv2 | pan-cancer | AAC | 0.0058 | 0.9 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | 0.0069 | 0.9 |
| mRNA | GSK2636771 | CTRPv2 | pan-cancer | AAC | -0.0078 | 0.9 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | -0.0099 | 0.9 |
| mRNA | Sunitinib | CTRPv2 | pan-cancer | AAC | 0.006 | 0.9 |
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | -0.0063 | 0.9 |
| mRNA | AZD8055 | CTRPv2 | pan-cancer | AAC | -0.006 | 0.9 |
| mRNA | BRD-K90370028 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.9 |
| mRNA | Pazopanib | GDSC1000 | pan-cancer | AAC | -0.0057 | 0.9 |
| mRNA | CAY10576 | CTRPv2 | pan-cancer | AAC | -0.0067 | 0.9 |